Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5H95B | — |
Patient received a dose of Kinrix out of the recommended age (patient is less than 4 years old).; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. On 29-JUL-2024, the patient received Kinrix. On 29-JUL-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Patient received a dose of Kinrix out of the recommended age (patient is less than 4 years old).). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-JUN-2025 The register nurse called to report that they administered a dose of Kinrix to 6 different patients under the age of 4 years old. The reporter asked that did they need to continue with the same schedule as recommended in the PI. The male patient was 3 years old now, he received Kinrix on 29th July 2024 which led to inappropriate age at vaccine administration.; Sender's Comments: US-GSK-US2025076587:Same reporter/Diffrent patient US-GSK-US2025076584:Same reporter/Diffrent patient US-GSK-US2025076588:Same reporter/Diffrent patient US-GSK-US2025076592:Same reporter/Diffrent patient